Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Angel & family office | 1 | 33% |
| Other / undisclosed | 2 | 67% |
Glycoscience company developing heparan sulfate therapies and enzyme replacement therapy
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Angel & family office | 1 | 33% |
| Other / undisclosed | 2 | 67% |